Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Appetite stimulation" patented technology

Dronabinol is one such cannaboid labeled for use in appetite stimulation, especially for chemotherapy patients. It provides standardized concentrations of tetrahydrocannabinol, or THC, the psychotropic compound contained in Cannabis sativa L, or marijuana.

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Use of Ghrelin Splice Variant for Treating Cachexia and/or Anorexia and/or Anorexia-Cachexia and/or Malnutrition and/or Lipodystrophy and/or Muscle Wasting and/or Appetite-Stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Chinese herbal medicine for regulating stomach and stimulating appetite of stiff pigs and preparation method thereof

The invention discloses a Chinese herbal medicine for coordinating the intestines and stomach of a cad pig and stimulating appetite, which is mainly composed of the following components in parts by weight: 30-50 parts of cassia bark, 20-40 parts of cumin, 20-40 parts of fleece-flower root, 20-40 parts of asket fern, 3-6 parts of pepper, 8-12 parts of notopterygium root, 20-30 parts of pericarpium citri reticulatae, 30-50 parts of gelsemium, 25-40 parts of radix astragali, 20-30 parts of folium artemisiae argyi, 180-220 parts of medicated leaven, 20-30 parts of malt, 18-22 parts of radix geutianae and 3-8 parts of licorice. The invention also discloses a preparation method of the Chinese herbal medicine, which is implemented by softening prepared powder by steaming in a steaming oven of a steamer for 1-3 hours, thereby obtaining the product. The Chinese herbal medicine has the effects of expelling and inhibiting insects, dredging the intestines, relieving dyspepsia, reinforcing the spleen to promote digestion, removing heat and dampness and activating blood circulation to dissipate blood stasis. After being eaten by a cad pig, the Chinese herbal medicine has the functions of dredging the blood vessels, reinforcing spleen to promote digestion and stimulating appetite.
Owner:重庆木犴生猪养殖有限公司

Beautifying and appetite stimulating mushroom stem gastronomic colloid sauce and preparation method thereof

The invention discloses beautifying and appetite stimulating mushroom stem gastronomic colloid sauce and a preparation method thereof. The beautifying and appetite stimulating mushroom stem gastronomic colloid sauce is prepared from the following raw materials in parts by weight: 300 to 350 parts of mushroom stems, 100 to 120 parts of corn, 10 to 12 parts of fennel, 10 to 12 parts of common salt, 15 to 18 parts of white granulated sugar, 20 to 23 parts of ground pepper, 10 to 12 parts of five spice powder, 10 to 12 parts of tea polyphenol, 12 to 13 parts of perilla leaves, 30 to 35 parts of hawthorn paste, 30 to 35 parts of rice wine, 10 to 12 parts of flaxseed gum, 10 to 12 parts of pepper, 11 to 13 parts of gelatin, 100 to 120 parts of soybeans, 30 to 35 parts of fish oil, 15 to 18 parts of mulberries and a proper amount of olive oil. The beautifying and appetite stimulating mushroom stem gastronomic colloid sauce has the proper sauce thickness, uniform material quality and spicy, hot, fresh and delicious taste; the mushroom dices have proper hardness and are chewy; the chewiness is good; the mushroom flavor is intense; the contained active ingredients have the health care efficacies of beautification, appetite stimulation, aging resistance, cancer resistance and the like.
Owner:HEFEI LONGLE FOODS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products